Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01374919 · ClinicalTrials.gov registry record · NA

Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia

A NA study of Iron Deficiency Anemia, sponsored by Auerbach Hematology Oncology Associates P C.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT01374919: Completed NA study of Iron Deficiency Anemia, sponsored by Auerbach Hematology Oncology Associates P C.

NCT01374919 is a NA study of Iron Deficiency Anemia that has completed, run by Auerbach Hematology Oncology Associates P C. The registered enrollment target is 60 participants, below the 191-participant average among 24 other Iron Deficiency Anemia trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01374919, a NA study of Iron Deficiency Anemia, has completed, sponsored by Auerbach Hematology Oncology Associates P C.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The aim of the study is to recruit 30 patients who have been referred to Auerach Hematology Oncology Assoc. for the treatment of iron defeciency anemia with iv iron (Ferumoxytol 1020 mg) administered via infusion pump over 15 minutes. To ascertain acute safety and tolerability of ferumoxytol during immediate post dosing observation period. Assess additional safety profile and laboratory assessment at follow up visit and interim telephone follow up.

Primary Outcome

Percentage of participates with indicated increase in hemoglobin from baseline to week 4 and week 8

Conditions Studied

Interventions

  • DRUG ferumoxytol

Study Locations (1)

Maryland

  • Auerbach Hematology and Oncology - Baltimore

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2011-06
Est. Completion 2012-03
Phase NA

What the finished NCT01374919 record still lists

NCT01374919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 191-participant average among 24 other Iron Deficiency Anemia trials with a reported enrollment target (69% lower).

The record links to 1 condition, with Iron Deficiency Anemia appearing as the primary indexed condition, and to 1 intervention - of which ferumoxytol is the first listed.

NCT01374919 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT01374919 about?

NCT01374919 is a clinical study titled "Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia". The aim of the study is to recruit 30 patients who have been referred to Auerach Hematology Oncology Assoc. for the treatment of iron defeciency anemia with iv iron (Ferumoxytol 1020 mg) administered via infusion pump over 15 minutes. To ascertain acute safety and tolerability of ferumoxytol during...

What is the current status of trial NCT01374919?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2011-06. Estimated completion is 2012-03.

What conditions does trial NCT01374919 study?

This clinical trial studies the following conditions: Iron Deficiency Anemia.

What interventions are being tested in trial NCT01374919?

The interventions under investigation include: ferumoxytol (DRUG).

Who is sponsoring clinical trial NCT01374919?

This trial is sponsored by Auerbach Hematology Oncology Associates P C, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01374919 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Iron Deficiency Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01374919's enrollment target sits among peer trials

60 17th of 24 higher than 8 of 24 other Iron Deficiency Anemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Iron Deficiency Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01374919, the US trial registry maintained by the National Library of Medicine. NCT01374919 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.